TickerGuard
Buy Day today: Poor (44) Weak market breadth · today: Core PCE (August) ≈
KPTI

Karyopharm Therapeutics Inc

Healthcare · Biotechnology

1.80$ -3.3% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Cash Flow

All figures per share in USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow KPTI
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
-24.79 -39.60 -33.74 -24.09 -2.80 -3.08 -2.22 -21.36 -27.40 -12.18 -15.69 -6.89
0.16 0.27 0.29 0.23 0.01 0.02 0.01 0.16 0.11 0.07 0.04 -0.01
6.86 7.18 8.91 6.67 0.30 0.25 0.34 5.94 6.49 2.85 2.27 1.28
6.88 7.18 8.91 6.67 0.30 0.25 0.34 7.38 6.43 – – –
4.68 1.68 0.39 10.77 0.00 -0.21 0.02 -4.62 -3.66 4.13 -0.04 2.59
1.37 0.60 0.03 0.02 0.04 0.00 0.00 1.14 0.02 0.00 0.02 0.00
-32.29 -38.25 9.83 5.59 -1.90 1.27 -0.75 28.29 -19.10 1.04 11.75 3.97
0.00 0.00 0.00 0.00 – – – – – – – –
54.50 0.26 0.25 0.28 0.06 0.07 0.14 0.75 0.73 – 13.66 –
– 70.28 66.71 54.54 2.94 – – – 0.00 0.00 10.25 2.47
54.50 39.04 20.45 24.75 5.57 2.01 2.39 14.69 35.50 0.15 5.13 2.75
-2.58 -38.85 -3.48 6.32 0.87 0.19 -0.58 21.60 -11.10 -10.99 1.18 -0.18
-26.15 -40.19 -33.76 -24.11 -2.84 -3.08 -2.23 -22.50 -27.42 -12.18 -15.71 -6.89

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?